Topic:

Manufacturing

Latest Headlines

Latest Headlines

GSK's ViiV unit to work with China's Desano to make API of Tivicay for access use

The API of GlaxoSmithKline's HIV therapy Tivicay (dolutegravir) will be made in China by Shanghai-based Desano Pharmaceuticals under a deal with the British drug maker's ViiV Healthcare arm, according to a press release.

India's Marksans Pharma buys U.S.-based Time-Cap, a trend in the making?

More than a few analysts and company executives are watching Indian drug companies in expectations of consolidation among smaller players and possibly daring moves by mid-cap and larger at home and abroad.

Troubled India's Wockhardt sees third U.S. drug recall in as many months

India's Wockhardt has voluntarily recalled 85,000 cartons of over-the-counter heartburn treatment famotidine tablets, calling the state of its plans to recover from U.S. FDA import bans on two plants into further question, Business Line said.

Novasep bets $11M on armed antibody R&D

French contract drugmaker Novasep is investing €10 million ($11 million) to build an antibody-drug conjugate facility at its Le Mans outpost.

India's drug watchdog calls all hands on deck in largest ever inspection effort

India's Central Drugs and Standards Control Organisation (CDSCO)  has told staff to forget holidays and weekends as it undertakes a massive drug inspection exercise it intends to complete by the end of the year.

J&J, Stryker, Zimmer in line as India eyes price caps on orthopedic implants

India may soon make scuttlebutt on medical device price controls a reality, starting with orthopedic implants, the Times of India reports, as the National Pharmaceutical Pricing Authority asks Johnson & Johnson, Zimmer and Stryker to submit details of production and pricing of their products, including those for knee and hip.

India's Kumar eyes a one-stop shop on pharmaceuticals

India's alphabet soup of ministries and agencies that have a role in national pharmaceutical policies will have to get to know each other better under the latest big idea to streamline decision-making and set policies.

Mylan's Bangalore unit cancer drug recall expanded as firm works M&A angles

Mylan has filled out details on an expanded recall of two drugs manufactured by Bangalore-based Agila Onco, which it bought from Strides Arcolab two years ago, as the company works to fend off a takeover offer from Teva Pharmaceuticals, while moving on its own unsolicited bid for Perrigo.

NanoCarrier aims for PhI study on neck cancer in Japan for NC-6004

In something of a surprise move, Japan's NanoCarrier submitted a Phase I application to the Pharmaceuticals and Medical Devices Agency for oncology candidate NC-6004, Nanoplatin, on June 9.

India's Jubilant Life Sciences turns a manufacturing corner

Jubilant Life Sciences has turned a corner at its HollisterStier sterile manufacturing facility in Washington state, highlighting an Indian success story of sorts on the long road of U.S. FDA manufacturing inspections.